Yahoo Web Search

  1. Ads

    related to: AbbVie
  2. See What AbbVie Does To Make An Impact On Patients' Lives. Learn About What We Care About. Find The Company's Mission, Principles & Culture. See What We Do Beyond Treating Diseases.

    • Investor Resources

      Find Financial Reports, Stock Info

      And More Resources For Investors.

    • Our Science

      See How We Impact Lives.

      More Than Developing Medicines.

Search results

  1. AbbVie is a global biopharmaceutical company that invests in science and innovation to treat 75+ conditions and improve lives. Learn about its R&D, partnerships, sustainability, careers and investor resources.

  2. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.

  3. en.wikipedia.org › wiki › AbbVieAbbVie - Wikipedia

    AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74.

    • c. 50,000 (Jan 2023)
    • US$58.05 billion (2022)
  4. www.abbvie.com › patients › productsProducts | AbbVie

    May 7, 2024 · AbbVie is a global biopharmaceutical company that offers products for various conditions across all stages of life. Browse the alphabetical list of products by name, including prescription drugs, ophthalmic solutions, regenerative tissue matrices, and more.

  5. AbbVie offers a range of patient support programs and services to help patients access and afford its medicines. Learn about myAbbVie Assist, bridge programs, co-pay assistance, partnerships and more.

  6. AbbVie is a global biopharmaceutical company that puts patients first in its research, development and access programs. Learn how AbbVie creates medicines and solutions that make a difference in people's lives, and explore its partnerships, sustainability and patient support initiatives.

  7. Nov 30, 2023 · NORTH CHICAGO, Ill., and WALTHAM, Mass., Nov. 30, 2023 / PRNewswire / -- AbbVie Inc. (NYSE: ABBV) and ImmunoGen, Inc. (NASDAQ: IMGN) today announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship cancer therapy ELAHERE ® (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC ...

  8. People also ask

  1. Ads

    related to: AbbVie
  2. See What AbbVie Does To Make An Impact On Patients' Lives. Learn About What We Care About. Find The Company's Mission, Principles & Culture. See What We Do Beyond Treating Diseases.

  1. People also search for